In a nulliparous woman at 40 weeks gestation with a cervix 0 cm dilated, should we proceed with induction using cervical ripening (e.g., dinoprostone or Foley balloon) or wait for spontaneous labor?

Induction at 40 Weeks with Unfavorable Cervix: Proceed with Cervical Ripening

For a nulliparous patient at 40 weeks with a 0 cm dilated cervix, you should proceed with induction using cervical ripening rather than waiting for spontaneous labor. Based on the landmark ARRIVE trial, elective induction at 39-40 weeks in low-risk nulliparous women reduces cesarean delivery rates and hypertensive disorders without increasing perinatal morbidity 1.

Key Evidence from ARRIVE Trial

The ARRIVE trial (2019) enrolled over 6,000 low-risk nulliparous women, with 63% having an unfavorable cervix (Bishop score <5) at randomization 1. The trial compared induction at 39 weeks versus expectant management and found:

• Lower cesarean delivery rate with induction: 18.6% vs 22.2% (RR 0.84, p<0.001) 1
• Reduced hypertensive disorders: 9.1% vs 14.1% (RR 0.64, p<0.001) 1
• Number needed to treat: 28 women need induction to prevent 1 cesarean delivery 1
• Similar perinatal outcomes between groups 1

Importantly, the trial protocol specifically requested cervical ripening agents for women with unfavorable cervix, and labor management allowed at least 12 hours after cervical ripening completion before considering cesarean for "failed induction" 1.

Cervical Ripening Method Selection

For Your Patient (0 cm dilated):

Use a transcervical Foley balloon as first-line, with or without concurrent pharmacologic agents:

• Balloon catheters are most effective for decreasing time to delivery in nulliparous patients with unfavorable cervix 2
• Single and double balloons are equally effective; use volume >30 ml 2
• Adding misoprostol or oxytocin concurrently with balloon further expedites delivery 2, 3, 4

Specific Options:

1. Foley balloon + misoprostol: Decreases time to delivery compared to balloon alone 2, 3
2. Foley balloon + oxytocin: Safe and effective alternative when misoprostol contraindicated 2, 4
3. Dinoprostone (prostaglandin E2) alone: FDA-approved for ripening unfavorable cervix 5, though may take longer than combination methods 6

Why Not Wait for Spontaneous Labor?

At 40 weeks, expectant management carries risks:

• Higher rates of macrosomia (24.6% vs 7.6%, p<0.001) and shoulder dystocia (2.3% vs 0.3%, p=0.03) with waiting 7
• More meconium-stained fluid (20.3% vs 9.3%, p<0.001) and meconium aspiration syndrome (4% vs 1.3%, p=0.03) 7
• Increased hypertensive complications as pregnancy continues beyond 39-40 weeks 1
• One intrauterine fetal death occurred in the expectant management group in a study of 600 women 7

Clinical Algorithm

For nulliparous patient at 40 weeks, 0 cm dilated:

1. Confirm low-risk status (no medical/obstetric complications requiring earlier delivery)
2. Counsel patient on ARRIVE findings: induction reduces cesarean risk vs waiting
3. If patient chooses induction:
   • Place transcervical Foley balloon (>30 ml volume)
   • Add concurrent misoprostol OR oxytocin to expedite delivery
   • Allow ≥12 hours after ripening completion before diagnosing "failed induction"
4. If patient prefers expectant management:
   • Twice-weekly fetal monitoring
   • Plan delivery by 42 weeks maximum
   • Counsel about increased macrosomia/meconium risks

Important Caveats

• Patient preference matters: Both options are reasonable, but induction offers maternal benefits 1
• Adequate time is critical: Don't diagnose failed induction prematurely with unfavorable cervix 1
• BMI consideration: Higher BMI associated with increased cesarean risk regardless of method 6
• If first ripening attempt fails: Can repeat with either dinoprostone gel or oral misoprostol with 62-70% vaginal delivery success 8

The evidence strongly supports proceeding with induction using cervical ripening at 40 weeks rather than waiting, particularly given the proven reduction in cesarean delivery and hypertensive complications without increased neonatal risk.